Akash Ajmera, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1615 Delaware St, Longview, WA 98632 Phone: 360-414-2730 |
Dr. Jorge Cabrera Gabilondo, M.D. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1615 Delaware St, Longview, WA 98632 Phone: 360-414-2730 Fax: 360-414-2739 |
Dr. David Benjamin Liang, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1615 Delaware St, Longview, WA 98632 Phone: 360-414-2730 Fax: 360-414-2739 |
Dr. Anne Marie Breitinger, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1615 Delaware St, Peacehealth Specialty Clinic, Longview, WA 98632 Phone: 360-414-2730 Fax: 360-414-2739 |
Dr. Shyam Mohan Dang, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1615 Delaware St, Longview, WA 98632 Phone: 360-414-2730 |
News Archive
Cerus Corporation announced today that it has entered into an agreement with CSL Limited, Biotherapies division to distribute Cerus' INTERCEPT Blood System for platelets in Australia and New Zealand. The INTERCEPT Blood System is designed to provide increased protection from a broad range of transfusion-transmitted pathogens, including bacteria and emerging pathogens such as the dengue and chikungunya viruses.
Antibodies aren't the only immune cells needed to fight off COVID-19 -; T cells are equally important and can step up to do the job when antibodies are depleted, suggests a new Penn Medicine study of blood cancer patients with COVID-19 published in Nature Medicine.
Health Canada is advising consumers not to use products containing Aristolochic Acid, a naturally occurring toxin that can cause cancer, mutations in human cells, and end-stage kidney failure.
An Indiana University study found that a smoke-free air law implemented in an Indiana community did not hurt business at the off-track betting facility in that community. The findings, the researchers said, suggest there is "no economic reason for policymakers to exclude OTB facilities from smoke-free legislation."
The magnetic-assisted intervention is being introduced in the United States and Europe, with fewer than 15 systems installed at institutions worldwide. Developed by Stereotaxis, Inc., a St. Louis firm, the system was approved by the U.S. Food and Drug Administration in 2003.
› Verified 9 days ago